Palisade Bio, Inc. Common Stock

PALINASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
1.12 USD
↘ 0.02 (1.75%)AT CLOSE (03:59 PM EST)
1.15
↗ 0.03 (2.77%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
1.15
↗ 0.03 (2.77%)
🔴Market: CLOSED

Palisade Bio, Inc. Common Stock (PALI) trades at $1.12 per share. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. PALI is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$1.15
High?$1.15
Low?$1.08
Prev. Close?$1.14
Volume?1.5M
Avg. Volume?3.2M
VWAP?$1.11
Rel. Volume?0.46x
Bid / Ask
Bid?$1.10 × 1.9K
Ask?$1.17 × 3.5K
Spread?$0.07
Midpoint?$1.14
Valuation & Ratios
Market Cap?201.0M
Shares Out?179.3M
Float?173.3M
Float %?99.4%
P/E Ratio?N/A
P/B Ratio?1.79
EPS?-$0.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Themes
Biotech - Drug Development›Immunology & Autoimmune
Employees
14
Market Cap
201.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.palisadebio.com
Listed
2021-04-28
Address
7750 EL CAMINO REAL, SUITE 5200
CARLSBAD, CA 92009
Phone: (858) 704-4900
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
50
Piotroski F-Score?0/9Weak
Altman Z-Score?17.34Safe
Confidence?43%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.90%High
Short Interest?29.3M
Days to Cover?7.8
Free Float173.3M
Avg Daily Volume3.8M
Settlement Date2026-10-30
Financial Health
Current Ratio?20.16Strong
Quick Ratio?20.16Strong
Cash Ratio?19.50Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
80
1.79CHEAP▾
P/S?
Peers
100
S&P
3
402.03HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.8CHEAP▾
EV/Sales?
Peers
100
S&P
3
174.80HIGH▾
Returns & Efficiency
ROE?
S&P
3
-38.9%WEAK▾
ROA?
S&P
3
-36.9%WEAK▾
Cash Flow & Enterprise
FCF?$-26396000
Enterprise Value?$87.4M
Fundamentals ratios updated end of day
MarketsMoversWatchlist